在骨折修复过程中,Cyr61的输送促进了血管新生
Annemarie Lang1, Emily A Eastburn1,2, Mousa Younesi2
1Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, United States.
bioRxiv : the preprint server for biology
|April 15, 2024
概括
Cyr61 (61kD的丰富的氨酸血管诱导剂) 增强了血管形成,以改善骨的修复. 机械负荷可能会破坏这种效果,这表明针对血管供应不良的骨折提供有针对性的输送.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨修复经常受到血液供应不良和新血管形成不足 (新血管化) 的阻碍.
- Cyr61 (Cysteine-rich angiogenic inducer of 61kD),也称为CCN1,是一种参与骨折愈合的生长因子,受机械力量的影响.
- 了解Cyr61的作用对于开发改善骨再生的策略至关重要.
研究的目的:
- 在骨愈合过程中调查内源Cyr61的分布.
- 评估递送重组Cyr61对血管化骨再生的影响.
- 为了确定机械负荷如何影响Cyr61-介导的骨修复.
主要方法:
- 在小鼠大腿骨折模型中映射Cyr61分布.
- 在Cyr61治疗中对体生成和骨质基因表达进行了体外研究.
- 在体内评估重组Cyr61在骨折愈合和新血管化上的作用.
- 评估早期机械负荷对Cyr61诱导的新血管化的影响.
主要成果:
- 在体外,Cyr61治疗增强了血管生成 (新血管形成),但没有影响体生成或骨质基因表达.
- 在体内,Cyr61在小鼠的骨折修复过程中加速了新血管化,但没有改变软骨或骨的形成.
- 早期的机械负荷干扰了Cyr61驱动的新血管化.
结论:
- 再组合Cyr61的输送促进了血管生成,这是骨修复的关键因素,特别是在稳定固定的骨折中.
- Cyr61在治疗血管供应受损的骨折方面显示出治疗潜力.
- 机械负荷条件可以调节Cyr61治疗的疗效.
更多相关视频
06:10Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
2.3K
13:16Computed Tomography and Optical Imaging of Osteogenesis-angiogenesis Coupling to Assess Integration of Cranial Bone Autografts and Allografts
Published on: December 22, 2015
11.4K
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Fractures: Bone Repair
3.2K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.2K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
